Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study

Calcineurin inhibitors, including tacrolimus, are largely responsible for advances in allotransplantation. However, the nephrotoxicity associated with these immunosuppressants impairs patients' long-term survival after renal allograft. Therefore, novel regimens that minimize or even eliminate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Guang-hui, Chen, Zheng, Xu, Lu, Zhu, Jing-hui, Xiang, Peng, Ma, Jun-jie, Peng, Yan-wen, Li, Guang-hui, Chen, Xiao-yong, Fang, Jia-li, Guo, Yu-he, Zhang, Lei, Liu, Long-shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914271/
https://www.ncbi.nlm.nih.gov/pubmed/26933811
http://dx.doi.org/10.18632/oncotarget.7725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914271/
https://www.ncbi.nlm.nih.gov/pubmed/26933811
http://dx.doi.org/10.18632/oncotarget.7725

Ejemplares similares